| 1 |
Polymorphisms in drug metabolism genes as a risk factor for first-line anti-tuberculosis drug-induced liver injury |
|
| | Heikrujam Nilkanta Meitei, Anupama Pandey, Reena Haobam | | | Molecular Biology Reports. 2022; | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Implications of bedaquiline-resistant tuberculosis |
|
| | Gyanshankar P Mishra, Jasmin Mulani | | | The Lancet Infectious Diseases. 2022; 22(2): 166 | | | [Pubmed] [Google Scholar] [DOI] | |
|
